ZERION announces the appointment of Jakob Dynnes Hansen as Chief Financial Officer and Mónica González Heredia as Director of Regulatory Affairs.
Both joined ZERION’s management team in October 2020.
“In an ambitious biotech company as ZERION, the team is the most important and I am both excited and grateful that we have been able to attract such experienced and talented individuals as our new colleagues in ZERION. Jakob and Mónica are taking up key positions in the company and they will play leading roles in building the company in the years to come,” says Ole Wiborg, CEO of ZERION.
Jakob Dynnes Hansen
In addition to being responsible for financial operations, Jakob Dynnes Hansen will assume a key role in completing ZERION’s next financing round in the first half of 2021.
Jakob Dynnes Hansen joins ZERION with more than 20 years of experience as chief financial officer in the biotech industry and 9 years in investment banking. He has been responsible for the financial management in several biotech companies including Galecto Biotech, Asarina Pharma, Acesion Pharma and Zealand Pharma, and has overseen several public offerings and M&As. He holds an MBA from INSEAD and an M.Sc. in Economics from University of Copenhagen, Denmark.
Mónica González Heredia
As responsible for regulatory affairs, Mónica González Heredia will be instrumental in securing regulatory approval of ZERION’s first drug formulation developed by use of the company’s Dispersome technology.
Mónica González Heredia has extensive regulatory experience in both early and late drug development across the full range of therapeutic areas. Mónica has more than 15 years experience within the multinational pharmaceutical industry and joins ZERION from Chemo Group (Insud Pharma) where she has held a number of regulatory positions of ever-increasing responsibility, most recently as Head of Regulatory Affairs for solid dosage forms. Prior to that, Mónica worked in regulatory affairs and research and development quality assurance positions in Teva and Wyeth. She holds a Bachelor in Biology and Biotechnology from Complutense University in Madrid, Spain.